Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Clinical Pathology

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1309/PTBB5BPCKX8K9V69PMID 15716231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kallikrein 4 is a Predominantly Nuclear Protein and Is Overexpressed in Prostate Cancer

  2004cited by this paper
• EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

  2004cited by this paper
• Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

  2004cited by this paper
• High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

  2004cited by this paper
• Expression of angiogenesis-related genes in ovarian carcinoma – A clinicopathologic study

  2004cited by this paper
• The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

  2003cited by this paper
• Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin.

  2003cited by this paper
• Parallel overexpression of seven kallikrein genes in ovarian cancer.

  2003cited by this paper
• Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

  2003cited by this paper
• Overexpression of kallikrein 10 in epithelial ovarian carcinomas.

  2003cited by this paper
• Human kallikrein 8, a novel biomarker for ovarian carcinoma.

  2003cited by this paper
• Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.

  2003cited by this paper
• Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.

  2003cited by this paper
• PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.

  2003cited by this paper
• Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis.

  2003cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera

  2002cited by this paper
• Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.

  2002cited by this paper
• Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

  2002cited by this paper
• The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.

  2001cited by this paper
• The new human tissue kallikrein gene family: structure, function, and association to disease.

  2001cited by this paper
• The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions

  2001cited by this paper
• Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.

  2001cited by this paper
• Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.

  2001cited by this paper
• Distinctly Different Gene Structure of KLK4/KLK-L1/Prostase/ARM1 Compared with Other Members of the Kallikrein Family: Intracellular Localization, Alternative cDNA Forms, and Regulation by Multiple Hormones

  2001cited by this paper
• Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.

  2001cited by this paper
• Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

  2001cited by this paper
• Ets-1 mRNA Expression in Effusions of Serous Ovarian Carcinoma Patients Is a Marker of Poor Outcome

  2001cited by this paper
• Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.

  2001cited by this paper
• Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.

  2001cited by this paper
• Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation.

  2001cited by this paper
• Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.

  2001cited by this paper
• The Role of Desmin and N-Cadherin in Effusion Cytology: A Comparative Study Using Established Markers of Mesothelial and Epithelial Cells

  2001cited by this paper
• Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.

  2001cited by this paper
• Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.

  2000cited by this paper
• Localization of a New Prostate-specific Antigen-related Serine Protease Gene, KLK4, Is Evidence for an Expanded Human Kallikrein Gene Family Cluster on Chromosome 19q13.3–13.4*

  1999cited by this paper
• Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression.

  1999cited by this paper
• Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies

  1999cited by this paper
• Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.

  1999cited by this paper
• Diagnostic surgical pathology

  1994cited by this paper
• Cancer statistics

  1989cited by this paper

• Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients

  2019cites this paper
• Role of Amylase in Ovarian Cancer

  2017cites this paper
• Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer

  2015cites this paper
• The Role of the Tumor Stroma in Ovarian Cancer

  2014cites this paper
• Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies

  2013cites this paper
• Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment

  2013cites this paper
• Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion.

  2013cites this paper
• Cytologic features and diagnostic accuracy of analysis of effusions for detection of ovarian carcinoma in dogs.

  2012cites this paper
• Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients

  2012cites this paper
• Ovarian/Primary Peritoneal Carcinoma

  2012cites this paper
• Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients

  2012cites this paper
• Cancer Treatment and Research: Preface

  2009cites this paper
• The human kallikrein gene family: new biomarkers for ovarian cancer.

  2009cites this paper
• Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

  2009cites this paper
• Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs)

  2008cites this paper
• A Multiparametric Serum Kallikrein Panel for Diagnosis of Non–Small Cell Lung Carcinoma

  2008cites this paper
• A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

  2007cites this paper
• Anatomic site-related expression of cancer-associated molecules in ovarian carcinoma.

  2007cites this paper
• Ovarian cancer specific kallikrein profile in effusions.

  2007cites this paper
• Kallikrein 4 is expressed in malignant mesothelioma—Further evidence for the histogenetic link between mesothelial and epithelial cells

  2007cites this paper
• Human tissue kallikreins : The cancer biomarker family q

  2007cites this paper
• Human tissue kallikreins: the cancer biomarker family.

  2007cites this paper
• Cellular distribution of human tissue kallikreins: immunohistochemical localization

  2006cites this paper